Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC9498181

Lonza Walkersville Basic Nucleofector Kit for Primary Mammalian Endothelial Cells

Catalog No. NC9498181
Encompass

In addition to various cell type-specific kits for primary endothelial cells, we also provide a cell group-specific Basic Nucleofector Kit. This kit is suited to determine the optimal transfection conditions for any mammalian endothelial cell type that lacks a cell type specific Optimized Protocol for the Nucleofector 2b Device (or older generations I or II). In a first experiment a selection of different Nucleofector Programs is tested in combination with the Basic Nucleofector Solution for endothelial cells. Benefits:Optimization can be performed within 1 experiment Detailed protocol guiding through the optimization procedure Optional result fine tuning with help of our Scientific Support Team Transfection efficiencies up to 90%Viabilities up to 85%Applications:Kit suited for endothelial cells from different mammalian species and various organsAlready tested for human pulmonary artery endothelial cells

Catalog No. NC9498181 Supplier Lonza Walkersville Supplier No. VPI1001
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

In addition to various cell type-specific kits for primary endothelial cells, we also provide a cell group-specific Basic Nucleofector Kit. This kit is suited to determine the optimal transfection conditions for any mammalian endothelial cell type that lacks a cell type specific Optimized Protocol for the Nucleofector 2b Device (or older generations I or II). In a first experiment a selection of different Nucleofector Programs is tested in combination with the Basic Nucleofector Solution for endothelial cells. Benefits:Optimization can be performed within 1 experiment Detailed protocol guiding through the optimization procedure Optional result fine tuning with help of our Scientific Support Team Transfection efficiencies up to 90%Viabilities up to 85%Applications:Kit suited for endothelial cells from different mammalian species and various organsAlready tested for human pulmonary artery endothelial cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.